Stephen Wargacki - May 10, 2024 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
Chief Science Officer
Signature
/s/ Lori Braender, as Attorney-In-Fact
Stock symbol
AQST
Transactions as of
May 10, 2024
Transactions value $
$0
Form type
4
Date filed
5/13/2024, 01:40 PM
Previous filing
Oct 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AQST Common Stock Award $0 +10K +3.88% $0.00 268K May 10, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.